Abstract
Metronidazole (MTZ)-resistant trichomoniasis is an uncommon condition which is a significant therapeutic challenge. To date, combination therapy with high dose oral tinidazole (TDZ) and vaginal paromomycin (PARO) cream has been successful in all published cases, but it is unclear whether the results are from these medications singly or together.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
